Eversept Partners, LP Lexicon Pharmaceuticals, Inc. Transaction History

Eversept Partners, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $1.56 Million - $3.1 Million	-797,694 Closed	0 $0
Q4 2021 Nov 08, 2023	SELL	$3.81 - $6.16 $285,750 - $462,000	-75,000 Reduced 8.59%	797,694 $3.14 Million
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $285,750 - $462,000	-75,000 Reduced 8.59%	797,694 $3.14 Million
Q3 2021 Nov 08, 2023	BUY	$3.38 - $5.35 $2.17 Million - $3.44 Million	643,405 Added 280.61%	872,694 $4.2 Million
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $2.17 Million - $3.44 Million	643,405 Added 280.61%	872,694 $4.2 Million
Q2 2021 Nov 08, 2023	SELL	$4.12 - $5.87 $746,972 - $1.06 Million	-181,304 Reduced 44.16%	229,289 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $746,972 - $1.06 Million	-181,304 Reduced 44.16%	229,289 $1.05 Million
Q1 2021 Nov 08, 2023	BUY	$3.45 - $9.09 $1.42 Million - $3.73 Million	410,593 New	410,593 $2.41 Million
Q1 2021 May 13, 2021	BUY	$3.45 - $9.09 $1.42 Million - $3.73 Million	410,593 New	410,593 $2.41 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.